CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands		Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2019		$ 172,029	$ 6	$ (33,484)	$ 347,564	$ 181	$ (142,238)
Beginning balance (in shares) at Dec. 31, 2019			63,657,000	4,145,000
Increase (Decrease) in Equity
Net Loss		(136,450)					(136,450)
Foreign currency translation adjustment		(200)				(200)
Sale of common stock, net of issuance cost		$ 339			339
Sale of common stock, net of issuance cost (in shares)		200,000	200,000
Stock issued under employee stock purchase plan		$ 123			123
Stock issued under employee stock purchase plan (in shares)				(78,000)
Restricted stock granted		$ 1	$ 1
Restricted stock granted (in shares)		3,114,978	3,201,000
Restricted stock forfeited (in shares)		0		(1,302,000)
Restricted units vested		$ (253)		$ (253)
Treasury stock purchased (in shares)		145,703		146,000
Stock compensation expense		$ 3,044			3,044
Shares withheld to cover taxes (in shares)				(66,000)
Stock issued in JP3 acquisition		$ 8,538	$ 1		8,537
Stock issued in JP3 acquisition (shares)		11,500,000	11,500,000
Stock options exercised (in shares)		111,298	111,000
Stock options exercised				$ (114)	114
Ending balance at Dec. 31, 2020		$ 47,171	$ 8	$ (33,851)	359,721	(19)	(278,688)
Ending balance (in shares) at Dec. 31, 2020			78,669,000	5,581,000
Increase (Decrease) in Equity
Net Loss		(30,526)					(30,526)
Foreign currency translation adjustment		$ 100				100
Sale of common stock, net of issuance cost (in shares)		0
Stock issued under employee stock purchase plan		$ 80			80
Stock issued under employee stock purchase plan (in shares)				(136,000)
Restricted stock granted (in shares)		1,702,289	1,702,000
Restricted stock forfeited (in shares)		(284,334)	(284,000)	(422,000)
Treasury stock purchased (in shares)		155,317
Restricted units vested (in shares)			86,000
Stock compensation expense		$ 3,757			3,757
Shares withheld to cover taxes		(423)		$ (273)	(150)
Shares withheld to cover taxes (in shares)			(76,000)	(155,000)
Other		33		$ 24	9
Other (shares)	[1]		(613,000)
Stock issued in JP3 acquisition		$ 0
Stock issued in JP3 acquisition (shares)		0
Stock options exercised (in shares)		0
Ending balance at Dec. 31, 2021		$ 20,192	$ 8	$ (34,100)	$ 363,417	$ 81	$ (309,214)
Ending balance (in shares) at Dec. 31, 2021			79,484,000	6,022,000

[1] See Note 16, “Stockholders’ Equity” for further discussion.